Advances in cell-based therapy for peripheral vascular disease

Arnon Blum, Wayne Balkan, Joshua M. Hare

Research output: Contribution to journalArticle

Abstract

Evidence is accumulating to support cell-based therapies as a new approach for chronic diseases. Perhaps the area of greatest impact, in terms of patient numbers, is cardiovascular disorders. This review considers cell transplantation as a potential treatment for peripheral vascular disease, including ischemic stroke and erectile dysfunction. Bone marrow derived cells are required for endogenous repair in adult individuals affected by angiopathies. Clinical trials using progenitor cells generated from monocytic or non-monocytic cells indicate that both are effective, suggesting that angiogenesis is the result of cross talk between different cells and pathways. Currently, there are 14 registered clinical trials (ClinicalTrials.gov) examining different approaches to stem cell therapy to cure peripheral artery disease, of which 6 have completed enrollment. Here, we will review published clinical studies that used cell transplantation for peripheral vascular ischemic disorders.

Original languageEnglish (US)
Pages (from-to)269-277
Number of pages9
JournalAtherosclerosis
Volume223
Issue number2
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Peripheral Vascular Diseases
Cell Transplantation
Cell- and Tissue-Based Therapy
Stem Cells
Clinical Trials
Peripheral Arterial Disease
Erectile Dysfunction
Bone Marrow Cells
Blood Vessels
Chronic Disease
Stroke
Therapeutics
Clinical Studies

Keywords

  • Cerebral vascular accident
  • Erectile dysfunction
  • Peripheral vascular disease
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Advances in cell-based therapy for peripheral vascular disease. / Blum, Arnon; Balkan, Wayne; Hare, Joshua M.

In: Atherosclerosis, Vol. 223, No. 2, 08.2012, p. 269-277.

Research output: Contribution to journalArticle

Blum, Arnon ; Balkan, Wayne ; Hare, Joshua M. / Advances in cell-based therapy for peripheral vascular disease. In: Atherosclerosis. 2012 ; Vol. 223, No. 2. pp. 269-277.
@article{d9a9bbcae05045118de93fe1eb3abc29,
title = "Advances in cell-based therapy for peripheral vascular disease",
abstract = "Evidence is accumulating to support cell-based therapies as a new approach for chronic diseases. Perhaps the area of greatest impact, in terms of patient numbers, is cardiovascular disorders. This review considers cell transplantation as a potential treatment for peripheral vascular disease, including ischemic stroke and erectile dysfunction. Bone marrow derived cells are required for endogenous repair in adult individuals affected by angiopathies. Clinical trials using progenitor cells generated from monocytic or non-monocytic cells indicate that both are effective, suggesting that angiogenesis is the result of cross talk between different cells and pathways. Currently, there are 14 registered clinical trials (ClinicalTrials.gov) examining different approaches to stem cell therapy to cure peripheral artery disease, of which 6 have completed enrollment. Here, we will review published clinical studies that used cell transplantation for peripheral vascular ischemic disorders.",
keywords = "Cerebral vascular accident, Erectile dysfunction, Peripheral vascular disease, Stem cell transplantation",
author = "Arnon Blum and Wayne Balkan and Hare, {Joshua M.}",
year = "2012",
month = "8",
doi = "10.1016/j.atherosclerosis.2012.03.017",
language = "English (US)",
volume = "223",
pages = "269--277",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Advances in cell-based therapy for peripheral vascular disease

AU - Blum, Arnon

AU - Balkan, Wayne

AU - Hare, Joshua M.

PY - 2012/8

Y1 - 2012/8

N2 - Evidence is accumulating to support cell-based therapies as a new approach for chronic diseases. Perhaps the area of greatest impact, in terms of patient numbers, is cardiovascular disorders. This review considers cell transplantation as a potential treatment for peripheral vascular disease, including ischemic stroke and erectile dysfunction. Bone marrow derived cells are required for endogenous repair in adult individuals affected by angiopathies. Clinical trials using progenitor cells generated from monocytic or non-monocytic cells indicate that both are effective, suggesting that angiogenesis is the result of cross talk between different cells and pathways. Currently, there are 14 registered clinical trials (ClinicalTrials.gov) examining different approaches to stem cell therapy to cure peripheral artery disease, of which 6 have completed enrollment. Here, we will review published clinical studies that used cell transplantation for peripheral vascular ischemic disorders.

AB - Evidence is accumulating to support cell-based therapies as a new approach for chronic diseases. Perhaps the area of greatest impact, in terms of patient numbers, is cardiovascular disorders. This review considers cell transplantation as a potential treatment for peripheral vascular disease, including ischemic stroke and erectile dysfunction. Bone marrow derived cells are required for endogenous repair in adult individuals affected by angiopathies. Clinical trials using progenitor cells generated from monocytic or non-monocytic cells indicate that both are effective, suggesting that angiogenesis is the result of cross talk between different cells and pathways. Currently, there are 14 registered clinical trials (ClinicalTrials.gov) examining different approaches to stem cell therapy to cure peripheral artery disease, of which 6 have completed enrollment. Here, we will review published clinical studies that used cell transplantation for peripheral vascular ischemic disorders.

KW - Cerebral vascular accident

KW - Erectile dysfunction

KW - Peripheral vascular disease

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84864773740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864773740&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2012.03.017

DO - 10.1016/j.atherosclerosis.2012.03.017

M3 - Article

C2 - 22494624

AN - SCOPUS:84864773740

VL - 223

SP - 269

EP - 277

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -